Sublobar Resection Versus Lobectomy for Early-Stage Lung Cancer: A Debate
Society of Thoracic Surgeons - Surgeon
NOVEMBER 3, 2023
Plan to attend Part 2 on Thursday, December 14, titled " Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC." While both trials showed similar results, there are important differences in design, demographics, and patients’ outcomes.
Let's personalize your content